Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Prostate gland lengths and iceball dimensions predict micturition functional outcome following salvage prostate cryotherapy in men with radiation recurrent prostate cancer.

Ahmad I, Kalna G, Ismail M, Birrell F, Asterling S, McCartney E, Greene D, Davies J, Leung HY.

PLoS One. 2013 Aug 9;8(8):e69243. doi: 10.1371/journal.pone.0069243. eCollection 2013.

2.

Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer.

Williams AK, Martínez CH, Lu C, Ng CK, Pautler SE, Chin JL.

Eur Urol. 2011 Sep;60(3):405-10. doi: 10.1016/j.eururo.2010.12.012. Epub 2010 Dec 21.

PMID:
21185115
3.

Salvage cryoablation of the prostate: followup and analysis of predictive factors for outcome.

Ng CK, Moussa M, Downey DB, Chin JL.

J Urol. 2007 Oct;178(4 Pt 1):1253-7; discussion 1257. Epub 2007 Aug 14.

PMID:
17698104
4.
5.

Salvage cryotherapy for radiation-recurrent prostate cancer: outcomes and complications.

Finley DS, Belldegrun AS.

Curr Urol Rep. 2011 Jun;12(3):209-15. doi: 10.1007/s11934-011-0182-4. Review.

6.

Predictors of biochemical failure in patients undergoing prostate whole-gland salvage cryotherapy: a novel risk stratification model.

Spiess PE, Levy DA, Mouraviev V, Pisters LL, Jones JS.

BJU Int. 2013 Aug;112(4):E256-61. doi: 10.1111/j.1464-410X.2012.11695.x. Epub 2013 Mar 7.

7.

Salvage focal prostate cryoablation for locally recurrent prostate cancer after radiotherapy: initial results from the cryo on-line data registry.

Li YH, Elshafei A, Agarwal G, Ruckle H, Powsang J, Jones JS.

Prostate. 2015 Jan;75(1):1-7. doi: 10.1002/pros.22881. Epub 2014 Oct 4.

PMID:
25283814
8.

Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy.

de Castro Abreu AL, Bahn D, Leslie S, Shoji S, Silverman P, Desai MM, Gill IS, Ukimura O.

BJU Int. 2013 Aug;112(3):298-307. doi: 10.1111/bju.12151.

9.

Incomplete glandular ablation after salvage cryotherapy for recurrent prostate cancer after radiotherapy.

Izawa JI, Morganstern N, Chan DM, Levy LB, Scott SM, Pisters LL.

Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):468-72.

PMID:
12738322
10.

Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study.

Baco E, Gelet A, Crouzet S, Rud E, Rouvière O, Tonoli-Catez H, Berge V, Chapelon JY, Eggesbø HB.

BJU Int. 2014 Oct;114(4):532-40. doi: 10.1111/bju.12545. Epub 2014 Apr 16.

12.

The efficacy and complications of salvage cryotherapy of the prostate.

Pisters LL, von Eschenbach AC, Scott SM, Swanson DA, Dinney CP, Pettaway CA, Babaian RJ.

J Urol. 1997 Mar;157(3):921-5.

PMID:
9072600
13.

Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up.

Bahn DK, Lee F, Silverman P, Bahn E, Badalament R, Kumar A, Greski J, Rewcastle JC.

Clin Prostate Cancer. 2003 Sep;2(2):111-4.

PMID:
15040872
14.

Outcomes of salvage prostate cryotherapy stratified by pre-treatment PSA: update from the COLD registry.

Spiess PE, Levy DA, Pisters LL, Mouraviev V, Jones JS.

World J Urol. 2013 Dec;31(6):1321-5. doi: 10.1007/s00345-012-0982-2. Epub 2012 Nov 23.

PMID:
23179729
15.

Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.

Hubosky SG, Fabrizio MD, Schellhammer PF, Barone BB, Tepera CM, Given RW.

J Endourol. 2007 Dec;21(12):1521-31. doi: 10.1089/end.2007.9875.

PMID:
18186694
16.

Salvage cryosurgery for locally recurrent prostate cancer after primary cryotherapy.

Chang X, Liu T, Zhang F, Zhao X, Ji C, Yang R, Gan W, Zhang G, Li X, Guo H.

Int Urol Nephrol. 2015 Feb;47(2):301-5. doi: 10.1007/s11255-014-0887-7. Epub 2014 Dec 16.

PMID:
25510358
17.

HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.

Asimakopoulos AD, Miano R, Virgili G, Vespasiani G, Finazzi Agrò E.

Urol Oncol. 2012 Sep;30(5):577-83. doi: 10.1016/j.urolonc.2010.08.019. Epub 2011 Feb 2.

PMID:
21292508
18.

Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.

Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L.

BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30.

19.

Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome.

Izawa JI, Madsen LT, Scott SM, Tran JP, McGuire EJ, Von Eschenbach AC, Pisters LL.

J Clin Oncol. 2002 Jun 1;20(11):2664-71.

PMID:
12039928
20.

Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients.

Ismail M, Ahmed S, Kastner C, Davies J.

BJU Int. 2007 Oct;100(4):760-4. Epub 2007 Jul 23.

Supplemental Content

Support Center